Entero Therapeutics, Inc.
ENTO
Revenue
0.00
0.000.00%
12 Months ChangeAssets
86.29M
▼-4.85M▼-5.32%
3 Months ChangeLiabilities
15.49M
▲2.22M▲16.70%
3 Months ChangeFree Cash Flow
-5.07M
▼-3.78M▼-291.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 10-Q
ID: 0001410578-24-001685
2024-09-11
Form 8-K
ID: 0001104659-24-098971
2024-09-10
Form 8-K
ID: 0001104659-24-098369
2024-09-03
Form 8-K
ID: 0001104659-24-096362
2024-08-29
Form 8-K
ID: 0001104659-24-094936
2024-08-23
Form 8-K
ID: 0001104659-24-092491
2024-08-22
Form 8-K
ID: 0001104659-24-092061
2024-08-15
Form 8-K
ID: 0001104659-24-089923
2024-08-07
Form 8-K
ID: 0001104659-24-086824
2024-07-31
Form 8-K
ID: 0001104659-24-084206